Research & Literature
Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.
Top Authors
Top Institutions
Finding nearby institutions...
Düsseldorf University Hospital
Düsseldorf, Germany
University of Miami
Coral Gables, United States
Centre National de la Recherche Scientifique
Paris, France
University of Cagliari
Cagliari, Italy
Ludwig-Maximilians-Universität München
Munich, Germany
Dompé (Italy)
Milan, Italy
Massachusetts Eye and Ear Infirmary
Boston, United States
Tufts University
Medford, United States
Universidad de Oviedo
Oviedo, Spain
University of Nottingham
Nottingham, United Kingdom
References
References (69)
- 1
Synergistic effect of regenerating agent plus cord blood serum eye drops for the treatment of resistant neurotrophic keratitis: a case report and a hypothesis for pathophysiologic mechanism.
Giannaccare G, Fresina M, Vagge A, Versura P
International medical case reports journal 2015; (8()):277-81 doi:10.2147/IMCRJ.S89968.
PMID: 26586967 - 2
[Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].
Schilimow A, Wiechens B
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2017; (114(8)):745-747 doi:10.1007/s00347-016-0377-7.
PMID: 27766386 - 3
Corneal Epithelium-Derived Neurotrophic Factors Promote Nerve Regeneration.
Di G, Qi X, Zhao X, et al.
Investigative ophthalmology & visual science 2017; (58(11)):4695-4702 doi:10.1167/iovs.16-21372.
PMID: 28910445 - 4
Neurotrophic factors and corneal nerve regeneration.
Sacchetti M, Lambiase A
Neural regeneration research 2017; (12(8)):1220-1224 doi:10.4103/1673-5374.213534.
PMID: 28966630 - 5
Corneal Neurotization for Neurotrophic Keratopathy: Clinical Outcomes and In Vivo Confocal Microscopic and Histopathological Findings.
Ting DSJ, Figueiredo GS, Henein C, et al.
Cornea 2018; (37(5)):641-646 doi:10.1097/ICO.0000000000001522.
PMID: 29373338 - 6
Phase II Randomized, Double-Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.
Bonini S, Lambiase A, Rama P, et al.
Ophthalmology 2018; (125(9)):1332-1343 doi:10.1016/j.ophtha.2018.02.022.
PMID: 29653858 - 7
Neurotrophic keratopathy.
Dua HS, Said DG, Messmer EM, et al.
Progress in retinal and eye research 2018; (66()):107-131 doi:10.1016/j.preteyeres.2018.04.003.
PMID: 29698813 - 8
"Therapeutic Penetrating Keratoplasty: A Retrospective Review".
Roozbahani M, Hammersmith KM, Nagra PK, et al.
Eye & contact lens 2018; (44 Suppl 2()):S433-S441 doi:10.1097/ICL.0000000000000522.
PMID: 29944500 - 9
Neurotrophic keratitis: current challenges and future prospects.
Versura P, Giannaccare G, Pellegrini M, et al.
Eye and brain 2018; (10()):37-45 doi:10.2147/EB.S117261.
PMID: 29988739 - 10
Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma.
Galvis V, Niño CA, Tello A, et al.
Archivos de la Sociedad Espanola de Oftalmologia 2019; (94(2)):100-104 doi:10.1016/j.oftal.2018.06.003.
PMID: 30025986 - 11
Clinical Efficacy of Platelet-Rich Plasma in the Treatment of Neurotrophic Corneal Ulcer.
Wróbel-Dudzińska D, Alio J, Rodriguez A, et al.
Journal of ophthalmology 2018; (2018()):3538764 doi:10.1155/2018/3538764.
PMID: 30026985 - 12
Case Series: Management of Neurotrophic Keratitis from Familial Dysautonomia.
Scanzera AC, Shorter E
Optometry and vision science : official publication of the American Academy of Optometry 2018; (95(8)):678-681 doi:10.1097/OPX.0000000000001255.
PMID: 30063663 - 13
Role of corneal nerves in ocular surface homeostasis and disease.
Labetoulle M, Baudouin C, Calonge M, et al.
Acta ophthalmologica 2019; (97(2)):137-145 doi:10.1111/aos.13844.
PMID: 30225941 - 14
[Pathogenesis and epidemiology of neurotrophic keratopathy].
Mertsch S, Alder J, Dua HS, Geerling G
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2019; (116(2)):109-119 doi:10.1007/s00347-018-0823-9.
PMID: 30478498 - 15
[Clinical picture and diagnosis of neurotrophic keratopathy].
Messmer EM
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2019; (116(2)):120-126 doi:10.1007/s00347-018-0822-x.
PMID: 30535856 - 16
[Current and experimental treatment approaches for neurotrophic keratopathy].
Alder J, Mertsch S, Menzel-Severing J, Geerling G
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2019; (116(2)):127-137 doi:10.1007/s00347-018-0843-5.
PMID: 30707284 - 17
Neurotrophic keratopathy: Pros and cons of current treatments.
Di Zazzo A, Coassin M, Varacalli G, et al.
The ocular surface 2019; (17(4)):619-623 doi:10.1016/j.jtos.2019.09.002.
PMID: 31526824 - 18
Corneal Cells: Fine-tuning Nerve Regeneration.
Kowtharapu BS, Stachs O
Current eye research 2020; (45(3)):291-302 doi:10.1080/02713683.2019.1675175.
PMID: 31566418 - 19
Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial.
Pflugfelder SC, Massaro-Giordano M, Perez VL, et al.
Ophthalmology 2020; (127(1)):14-26 doi:10.1016/j.ophtha.2019.08.020.
PMID: 31585826 - 20
Neurotrophic keratitis: Frequency, etiologies, clinical management and outcomes.
Saad S, Abdelmassih Y, Saad R, et al.
The ocular surface 2020; (18(2)):231-236 doi:10.1016/j.jtos.2019.11.008.
PMID: 31759182 - 21
Corneal Neurotization: A Review of Pathophysiology and Outcomes.
Park JK, Charlson ES, Leyngold I, Kossler AL
Ophthalmic plastic and reconstructive surgery 2020; (36(5)):431-437 doi:10.1097/IOP.0000000000001583.
PMID: 31923091 - 22
Epithelial Plaque Formation Secondary to Recombinant Human Nerve Growth Factor.
Weinlander E, Ling J, Reddy A, Nallasamy N
Cornea 2020; (39(9)):1174-1176 doi:10.1097/ICO.0000000000002300.
PMID: 32141943 - 23
Amniotic membrane transplantation for managing dry eye and neurotrophic keratitis.
Mead OG, Tighe S, Tseng SCG
Taiwan journal of ophthalmology 2020; (10(1)):13-21 doi:10.4103/tjo.tjo_5_20.
PMID: 32309119 - 24
Direct Versus Indirect Corneal Neurotization for the Treatment of Neurotrophic Keratopathy: A Multicenter Prospective Comparative Study.
Fogagnolo P, Giannaccare G, Bolognesi F, et al.
American journal of ophthalmology 2020; (220()):203-214 doi:10.1016/j.ajo.2020.07.003.
PMID: 32659280 - 25
The molecular basis of neurotrophic keratopathy: Diagnostic and therapeutic implications. A review.
Ruiz-Lozano RE, Hernandez-Camarena JC, Loya-Garcia D, et al.
The ocular surface 2021; (19()):224-240 doi:10.1016/j.jtos.2020.09.007.
PMID: 33022412 - 26
[Cyanoacrylate adhesive in surgrical treatment of corneal perforation (clinical case)].
Trufanov SV
Vestnik oftalmologii 2020; (136(5. Vyp. 2)):232-236 doi:10.17116/oftalma2020136052232.
PMID: 33063970 - 27
On the Horizon: Biologics and Nutrients for Neurotrophic Keratitis.
Gumus K
Eye & contact lens 2021; (47(3)):154-156 doi:10.1097/ICL.0000000000000757.
PMID: 33156130 - 28
Surgical Management of the Ocular Surface in Neurotrophic Keratopathy: Amniotic Membrane, Conjunctival Grafts, Lid Surgery, and Neurotization.
Trinh T, Mimouni M, Santaella G, et al.
Eye & contact lens 2021; (47(3)):149-153 doi:10.1097/ICL.0000000000000753.
PMID: 33196502 - 29
[Consensus of experts on diagnosis and treatment of neurotrophic keratitis in China (2021)].
[Zhonghua yan ke za zhi] Chinese journal of ophthalmology 2021; (57(2)):90-94 doi:10.3760/cma.j.cn112142-20201028-00715.
PMID: 33541049 - 30
Neurotrophic Keratopathy: Ophthalmology's Diabetic Foot Problem.
Margolis TP
Eye & contact lens 2021; (47(3)):136-139 doi:10.1097/ICL.0000000000000774.
PMID: 33599469 - 31
Corneal Neurotization in the Setting of Facial Paralysis: A Comprehensive Review of Surgical Techniques.
Ziai K, Thomas S, Weller C, Lighthall JG
The Journal of craniofacial surgery 2021; (32(6)):2210-2214 doi:10.1097/SCS.0000000000007590.
PMID: 33654040 - 32
Neurotrophic keratitis after penetrating keratoplasty for lattice dystrophy.
Gouvea L, Penatti R, Rocha KM
American journal of ophthalmology case reports 2021; (22()):101058 doi:10.1016/j.ajoc.2021.101058.
PMID: 33718661 - 33
Bilateral Severe Corneal Ulcer in a Patient with Lung Adenocarcinoma Treated with Gefitinib.
Gozzi F, Tiseo M, Facchinetti F, et al.
Case reports in ophthalmology 2021; (12(1)):288-292 doi:10.1159/000514696.
PMID: 34054472 - 34
Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy.
Dana R, Farid M, Gupta PK, et al.
BMC ophthalmology 2021; (21(1)):327 doi:10.1186/s12886-021-02092-1.
PMID: 34493256 - 35
Neurotrophic Keratopathy After Herpes Zoster Ophthalmicus.
Meyer JJ, Liu K, McGhee CNJ, et al.
Cornea 2022; (41(11)):1433-1436 doi:10.1097/ICO.0000000000003003.
PMID: 35120347 - 36
Neurotrophic keratopathy: current challenges and future prospects.
NaPier E, Camacho M, McDevitt TF, Sweeney AR
Annals of medicine 2022; (54(1)):666-673 doi:10.1080/07853890.2022.2045035.
PMID: 35243932 - 37
Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis.
Roumeau S, Dutheil F, Sapin V, et al.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2022; (260(8)):2623-2637 doi:10.1007/s00417-022-05602-z.
PMID: 35254511 - 38
Management of descemetocele: Our experience and a simplified treatment algorithm.
Shankar S, Agarwal R, Nagpal R, et al.
Indian journal of ophthalmology 2022; (70(5)):1564-1570 doi:10.4103/ijo.IJO_3070_21.
PMID: 35502027 - 39
Characteristics of the ocular surface in neurotrophic keratitis induced by trigeminal nerve injury following neurosurgery.
Xie C, Liu B, Zhao X, et al.
International ophthalmology 2023; (43(4)):1229-1240 doi:10.1007/s10792-022-02521-0.
PMID: 36115903 - 40
Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines.
Vazirani J, Sridhar U, Gokhale N, et al.
Indian journal of ophthalmology 2023; (71(4)):1357-1363 doi:10.4103/IJO.IJO_2756_22.
PMID: 37026267 - 41
Efficacy of Plasma Rich in Growth Factors (PRGF) in Stage 1 Neurotrophic Keratitis.
Ghalibafan S, Osei K, Amescua G, Sabater A
Research square 2023; doi:10.21203/rs.3.rs-3040369/v1.
PMID: 37461454 - 42
Neurotrophic keratopathy: An updated understanding.
The ocular surface 2023; (30()):129-138 doi:10.1016/j.jtos.2023.09.001.
PMID: 37666470 - 43
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies.
Wajnsztajn D, Faraj LA, Sanchez-Tabernero S, Solomon A
Current opinion in allergy and clinical immunology 2023; (23(6)):520-528 doi:10.1097/ACI.0000000000000942.
PMID: 37694830 - 44
Chitosan-based thermosensitive hydrogel with long-term release of murine nerve growth factor for neurotrophic keratopathy.
Wu J, Huang Y, Yu H, et al.
Neural regeneration research 2024; (19(3)):680-686 doi:10.4103/1673-5374.380908.
PMID: 37721301 - 45
Phase IV Multicenter, Prospective, Open-Label Clinical Trial of Cenegermin (rhNGF) for Stage 1 Neurotrophic Keratopathy (DEFENDO).
Hamrah P, Massaro-Giordano M, Schanzlin D, et al.
Ophthalmology and therapy 2024; (13(2)):553-570 doi:10.1007/s40123-023-00866-y.
PMID: 38175466 - 46
Topical application of calcitonin gene-related peptide as a regenerative, antifibrotic, and immunomodulatory therapy for corneal injury.
Zidan AA, Zhu S, Elbasiony E, et al.
Communications biology 2024; (7(1)):264 doi:10.1038/s42003-024-05934-y.
PMID: 38438549 - 47
Substance P promotes transforming growth factor-β-induced collagen synthesis in human corneal fibroblasts.
Sugioka K, Nishida T, Murakami J, et al.
American journal of physiology. Cell physiology 2024; (326(5)):C1482-C1493 doi:10.1152/ajpcell.00084.2024.
PMID: 38525537 - 48
Corneal Neurotization for Neurotrophic Keratopathy: A Multicenter Experience.
Aujla J, Tong JY, Curragh D, et al.
Ophthalmic plastic and reconstructive surgery 2024; (40(6)):655-660 doi:10.1097/IOP.0000000000002684.
PMID: 38624152 - 49
Insights on the Choice and Preparation of the Donor Nerve in Corneal Neurotization for Neurotrophic Keratopathy: A Narrative Review.
Serra PL, Giannaccare G, Cuccu A, et al.
Journal of clinical medicine 2024; (13(8)) doi:10.3390/jcm13082268.
PMID: 38673540 - 50
Corneal Sensitivity Testing Procedure for Ophthalmologic and Optometric Patients.
Galor A, Lighthizer N
Journal of visualized experiments : JoVE 2024; doi:10.3791/66597.
PMID: 39158298 - 51
The THINK Study: Testing Hypoesthesia and the Incidence of Neurotrophic Keratopathy in Cataract Patients with Dry Eye.
Hovanesian JA
Clinical ophthalmology (Auckland, N.Z.) 2024; (18()):3627-3633 doi:10.2147/OPTH.S501452.
PMID: 39659875 - 52
Sandwich Technique and Amniotic Membrane Transplantation as an Effective Method in Repairing Corneal Perforations.
Ciftci MD, Selver OB
Middle East African journal of ophthalmology 2023; (30(4)):246-249 doi:10.4103/meajo.meajo_191_23.
PMID: 39959590 - 53
The Prevalence of Corneal Sensitivity Loss in Patients with and without Dry Eye Disease.
Stolz M
Clinical ophthalmology (Auckland, N.Z.) 2025; (19()):1323-1330 doi:10.2147/OPTH.S513005.
PMID: 40270622 - 54
Corneal Neurotization in Elderly Patients with Multimorbidity.
Holtmann C, Roth M, Beseoglu K, et al.
Current eye research 2025; (50(9)):886-893 doi:10.1080/02713683.2025.2509567.
PMID: 40452082 - 55
The pathogenesis, risk factors, diagnosis and treatment of Acanthamoeba keratitis.
Bao M, Bao H, Wang S, Zhou H
Frontiers in medicine 2025; (12()):1559224 doi:10.3389/fmed.2025.1559224.
PMID: 40776920 - 56
Cenegermin for the Treatment of Moderate or Severe Neurotrophic Keratopathy: Results from a Prospective, Phase IV, Open-Label Study in China.
Li S, Xu J, Yuan J, et al.
Ophthalmology and therapy 2025; (14(12)):3021-3033 doi:10.1007/s40123-025-01253-5.
PMID: 41046317 - 57
Efficacy of Corneal Neurotization Surgery in Eyes With Neurotrophic Keratopathy: A Systematic Review and Meta-Analysis.
Molinari ME, Huntermann R, Pedrotti Chavez M, et al.
Annals of plastic surgery 2025; (95(6)):672-679 doi:10.1097/SAP.0000000000004517.
PMID: 41071907 - 58
Profile and Management Outcomes of Neurotrophic Keratitis at A Tertiary Eye Hospital in Saudi Arabia: A Cohort Study.
Al Azaz R, Khandekar R, Al Ghadeer H
Clinical ophthalmology (Auckland, N.Z.) 2025; (19()):3815-3826 doi:10.2147/OPTH.S540546.
PMID: 41116972 - 59
Beyond the Surface: Revealing the Concealed Effects of Hyperglycemia on Ocular Surface Homeostasis and Dry Eye Disease.
Zeppieri M, Capobianco M, Visalli F, et al.
Medicina (Kaunas, Lithuania) 2025; (61(11)) doi:10.3390/medicina61111992.
PMID: 41303830 - 60
[Recurrence of herpetic eye disease following cataract surgery: risk factors and prevention].
Mackenbrock LHB, Xu ATL, Naujokaitis T, Khoramnia R
Die Ophthalmologie 2026; (123(5)):353-358 doi:10.1007/s00347-026-02411-1.
PMID: 41805863 - 61
Concomitant Tarsorrhaphy During Penetrating Keratoplasty for Promoting Epithelial Healing in Neurotrophic Keratopathy.
Huang RS, Agarwal M, Mimouni M, Chan CC
American journal of ophthalmology 2026; (287()):101-108 doi:10.1016/j.ajo.2026.03.027.
PMID: 41887389 - 62
Subclinical Corneal Neuropathy in Dry Eye Disease: A Driver of Ocular Surface Dysfunction?
Almaoui E, Calkins DJ, Wareham LK
Current eye research 2026; (51(9)):1044-1055 doi:10.1080/02713683.2026.2664593.
PMID: 42080236 - 63
Neurotrophic Keratopathy: Current Concepts, Management, and Emerging Treatments.
Cheung AY, Holland EJ
Cornea 2026; (45(6)):673-685 doi:10.1097/ICO.0000000000004055.
PMID: 42085714 - 64
Retrospective Evaluation of Successive Biovance Decellularized Basement Membrane Tissue Grafts for the Management of Chronic Subclinical and Stage 1 Neurotrophic Keratitis.
Ayres BD, Fram NR, Wu HK, et al.
Clinical ophthalmology (Auckland, N.Z.) 2026; (20()):599498 doi:10.2147/OPTH.S599498.
PMID: 42199330 - 65
Acute Calcific Band Keratopathy After Cenegermin Treatment for Neurotrophic Keratitis.
Morcos DM, Carbonell BA, Rao N, et al.
Cornea 2026; doi:10.1097/ICO.0000000000004192.
PMID: 42228417 - 66
[Corneal melting under PD-1/PD-L1 inhibition].
Jacobi LF, Thaler S, Bodenbender JP
Die Ophthalmologie 2026; (123(7)):549-552 doi:10.1007/s00347-026-02458-0.
PMID: 42268289 - 67
The neuro-immune-epithelial axis in dry eye: From pathogenic crosstalk to neuromodulatory therapies.
Zhang J, Li Z
Experimental eye research 2026; (270()):111133 doi:10.1016/j.exer.2026.111133.
PMID: 42320871 - 68
Therapeutic efficacy of cenegermin in the management of neurotrophic keratitis: a systematic review and meta-analysis of randomized controlled trials.
Faroog Z, Zaidi ARZ, Tejani S
Therapeutic advances in ophthalmology 2026; (18()):25158414261460347 doi:10.1177/25158414261460347.
PMID: 42368179 - 69
Making Corneal Sensation Testing Accessible: Bench Validation of a Low-Cost Adjustable Monofilament Aesthesiometer.
Maskill D
Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) 2026; (46(5)):1196-1201 doi:10.1007/s44402-026-00160-x.
PMID: 42536268